Bio/Pharma News

Dec 19, 2013
Merck and GlaxoSmithKline begin clinical trial of pazopanib for the treatment of advanced renal-cell carcinoma.
Dec 19, 2013
Everett Laboratories acquires Quinnova Pharmaceuticals, a specialty pharmaceutical company.
Dec 19, 2013
Bind Therapeutics amends its development and commercialization collaboration agreement with Amgen.
Dec 19, 2013
Encap will collaborate with Lipocine to manufacture Lipcine's oral testosterone product, LPCN 1021, for Phase III clinical trials.
Dec 17, 2013
By Pharmaceutical Technology Editors
AstraZeneca's MedImmune will collaborate with Johns Hopkins University in both biologics and small-molecule projects.
Dec 17, 2013
By Pharmaceutical Technology Editors
Merck's new facility for aseptic production in Reinbek, Germany is scheduled to be completed in 2016.
Dec 12, 2013
ScinoPharm completes new API manufacturing plant in Changshu, China.
Dec 12, 2013
Bristol-Myers Squibb has elected Thomas Lynch, Jr., MD to its board of directors.
Dec 12, 2013
AstraZeneca will receive $76 million in damages from Apotex Corp., Apotex, and Torpharm.
Dec 12, 2013
Johnson&Johnson will open a network of partnering offices across the UK.
native1_300x100
lorem ipsum